Treatment Guidelines from The Medical Letter
FROM
ISSUE
140
April 1, 2014
View Complete Issue         Table of Contents 2019 
Drugs for Peptic Ulcer Disease and GERD
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drugs for Peptic Ulcer Disease and GERD
April 1, 2014 (Issue: 140)
H2-RECEPTOR ANTAGONISTS (H2RAs) — Currently available H2RAs are listed in Table 1. These drugs inhibit the action of histamine at the H2-receptor of the gastric parietal cell, decreasing basal acid secretion and, to a lesser degree,...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Peptic Ulcer Disease and GERD
Article code: 140a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.